These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 37612278)

  • 1. C1GalT1 expression reciprocally controls tumour cell-cell and tumour-macrophage interactions mediated by galectin-3 and MGL with double impact on cancer development and progression.
    Wan Y; Adair K; Herrmann A; Shan X; Xia L; Duckworth CA; Yu LG
    Cell Death Dis; 2023 Aug; 14(8):547. PubMed ID: 37612278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and Impact of C1GalT1 in Cancer Development and Progression.
    Wan Y; Yu LG
    Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C1GALT1 overexpression promotes the invasive behavior of colon cancer cells through modifying O-glycosylation of FGFR2.
    Hung JS; Huang J; Lin YC; Huang MJ; Lee PH; Lai HS; Liang JT; Huang MC
    Oncotarget; 2014 Apr; 5(8):2096-106. PubMed ID: 24758762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential glycosylation of MUC1 and CEACAM5 between normal mucosa and tumour tissue of colon cancer patients.
    Saeland E; Belo AI; Mongera S; van Die I; Meijer GA; van Kooyk Y
    Int J Cancer; 2012 Jul; 131(1):117-28. PubMed ID: 21823122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. O-Glycosylation-mediated signaling circuit drives metastatic castration-resistant prostate cancer.
    Tzeng SF; Tsai CH; Chao TK; Chou YC; Yang YC; Tsai MH; Cha TL; Hsiao PW
    FASEB J; 2018 Jun; ():fj201800687. PubMed ID: 29906246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C1GALT1 enhances proliferation of hepatocellular carcinoma cells via modulating MET glycosylation and dimerization.
    Wu YM; Liu CH; Huang MJ; Lai HS; Lee PH; Hu RH; Huang MC
    Cancer Res; 2013 Sep; 73(17):5580-90. PubMed ID: 23832667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C1GALT1 in health and disease.
    Sun X; Zhan M; Sun X; Liu W; Meng X
    Oncol Lett; 2021 Aug; 22(2):589. PubMed ID: 34149900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of cell surface mucins with galectin-3 contributes to the ocular surface epithelial barrier.
    Argüeso P; Guzman-Aranguez A; Mantelli F; Cao Z; Ricciuto J; Panjwani N
    J Biol Chem; 2009 Aug; 284(34):23037-45. PubMed ID: 19556244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C1GALT1 promotes invasive phenotypes of hepatocellular carcinoma cells by modulating integrin β1 glycosylation and activity.
    Liu CH; Hu RH; Huang MJ; Lai IR; Chen CH; Lai HS; Wu YM; Huang MC
    PLoS One; 2014; 9(8):e94995. PubMed ID: 25089569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer.
    Lee PC; Chen ST; Kuo TC; Lin TC; Lin MC; Huang J; Hung JS; Hsu CL; Juan HF; Lee PH; Huang MC
    Oncogene; 2020 Mar; 39(13):2724-2740. PubMed ID: 32005975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C1GALT1 Seems to Promote In Vitro Disease Progression in Ovarian Cancer.
    Chou CH; Huang MJ; Liao YY; Chen CH; Huang MC
    Int J Gynecol Cancer; 2017 Jun; 27(5):863-871. PubMed ID: 28498248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C1GALT1 high expression is associated with poor survival of patients with pancreatic ductal adenocarcinoma and promotes cell invasiveness through integrin α
    Kuo TC; Wu MH; Yang SH; Chen ST; Hsu TW; Jhuang JY; Liao YY; Tien YW; Huang MC
    Oncogene; 2021 Feb; 40(7):1242-1254. PubMed ID: 33420364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-Regulation of C1GALT1 Enhances the Progression of Cholangiocarcinoma through Activation of AKT/ERK Signaling Pathways.
    Khiaowichit J; Talabnin C; Dechsukhum C; Silsirivanit A; Talabnin K
    Life (Basel); 2022 Jan; 12(2):. PubMed ID: 35207462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective Intestinal Mucin-Type O-Glycosylation Causes Spontaneous Colitis-Associated Cancer in Mice.
    Bergstrom K; Liu X; Zhao Y; Gao N; Wu Q; Song K; Cui Y; Li Y; McDaniel JM; McGee S; Chen W; Huycke MM; Houchen CW; Zenewicz LA; West CM; Chen H; Braun J; Fu J; Xia L
    Gastroenterology; 2016 Jul; 151(1):152-164.e11. PubMed ID: 27059389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galectin-3 promotes secretion of proteases that decrease epithelium integrity in human colon cancer cells.
    Li S; Pritchard DM; Yu LG
    Cell Death Dis; 2023 Apr; 14(4):268. PubMed ID: 37055381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galectin-8 expression decreases in cancer compared with normal and dysplastic human colon tissue and acts significantly on human colon cancer cell migration as a suppressor.
    Nagy N; Bronckart Y; Camby I; Legendre H; Lahm H; Kaltner H; Hadari Y; Van Ham P; Yeaton P; Pector JC; Zick Y; Salmon I; Danguy A; Kiss R; Gabius HJ
    Gut; 2002 Mar; 50(3):392-401. PubMed ID: 11839721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of C1GalT1 inhibits radioresistance of human esophageal cancer cells through modifying β1-integrin glycosylation.
    Zhang C; Deng X; Qiu L; Peng F; Geng S; Shen L; Luo Z
    J Cancer; 2018; 9(15):2666-2677. PubMed ID: 30087707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β4-Integrin/PI3K Signaling Promotes Tumor Progression through the Galectin-3-
    Kariya Y; Oyama M; Hashimoto Y; Gu J; Kariya Y
    Mol Cancer Res; 2018 Jun; 16(6):1024-1034. PubMed ID: 29549127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of C1GALT1 promotes breast cancer cell growth through MUC1-C signaling pathway.
    Chou CH; Huang MJ; Chen CH; Shyu MK; Huang J; Hung JS; Huang CS; Huang MC
    Oncotarget; 2015 Mar; 6(8):6123-35. PubMed ID: 25762620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-associated antigen 90K/Mac-2-binding protein: possible role in colon cancer.
    Ulmer TA; Keeler V; Loh L; Chibbar R; Torlakovic E; André S; Gabius HJ; Laferté S
    J Cell Biochem; 2006 Aug; 98(5):1351-66. PubMed ID: 16518858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.